R. L. Avery, S. Fekrat, B. S. Hawkins, and N. M. Bressler, NATURAL HISTORY OF SUBFOVEAL SUBRETINAL HEMORRHAGE IN AGERELATED MACULAR DEGENERATION. RETINA, vol.16, issue.3, p.183, 1996.

M. A. Hochman, C. M. Seery, and M. A. Zarbin, Pathophysiology and management of subretinal hemorrhage, Survey of Ophthalmology, vol.42, issue.3, pp.195-213, 1997.

M. H. Berrocal, M. L. Lewis, and H. W. Flynn, Variations in the Clinical Course of Submacular Hemorrhage, American Journal of Ophthalmology, vol.122, issue.4, pp.486-93, 1996.

A. Scupola, G. Coscas, G. Soubrane, and E. Balestrazzi, Natural History of Macular Subretinal Hemorrhage in Age-Related Macular Degeneration, OPH, vol.213, issue.2, pp.97-102, 1999.

H. Glatt and R. Machemer, Experimental subretinal hemorrhage in rabbits, Am J Ophthalmol. déc, vol.94, issue.6, pp.762-73, 1982.

M. W. Johnson, K. R. Olsen, and E. Hernandez, Tissue plasminogen activator treatment of experimental subretinal hemorrhage, Retina, vol.11, issue.2, pp.250-258, 1991.

H. Lewis, S. C. Resnick, J. G. Flannery, and B. R. Straatsma, Tissue plasminogen activator treatment of experimental subretinal hemorrhage, Am J Ophthalmol. 15 févr, vol.111, issue.2, pp.197-204, 1991.

J. D. Benner, A. Hay, M. B. Landers, L. M. Hjelmeland, and L. S. Morse, Fibrinolytic-assisted removal of experimental subretinal hemorrhage within seven days reduces outer retinal degeneration, Ophthalmology. avr, vol.101, issue.4, pp.672-81, 1994.

M. Inoue, F. Shiraga, Y. Shirakata, Y. Morizane, S. Kimura et al., Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm. Graefe's Archive for Clinical and Experimental Ophthalmology, vol.253, pp.1663-1672, 2015.

M. Abboud, M. Benzerroug, and S. Milazzo, Treatment of macular hematoma complicating AMD by vitrectomy, subretinal r-TPA injection

, J Fr Ophtalmol. févr, vol.40, issue.2, pp.133-140, 2017.

J. H. De-jong, E. Van-zeeburg, M. G. Cereda, M. Van-velthoven, K. Faridpooya et al., Retina, vol.36, issue.5, pp.914-939, 2016.

, Anatomie de l'OEil : la rétine, p.11, 2018.

D. Sur,

J. B. Jonas, C. Cheung, P. , and S. , Updates on the Epidemiology of Age-Related Macular Degeneration, Asia Pac J Ophthalmol (Phila). déc, vol.6, issue.6, pp.493-500, 2017.

L. Feeney-burns, E. S. Hilderbrand, and S. Eldridge, Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells, Invest Ophthalmol Vis Sci. févr, vol.25, issue.2, pp.195-200, 1984.

R. S. Ramrattan, T. L. Van-der-schaft, C. M. Mooy, W. C. De-bruijn, P. G. Mulder et al., Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging, Invest Ophthalmol Vis Sci. mai, vol.35, issue.6, pp.2857-64, 1994.

A. M. Fine, M. J. Elman, J. E. Ebert, P. A. Prestia, J. S. Starr et al., Earliest symptoms caused by neovascular membranes in the macula, Arch Ophthalmol. avr, vol.104, issue.4, pp.513-517, 1986.

L. L. Sloan, Variation of acuity with luminance in ocular diseases and anomalies, Doc Ophthalmol, vol.26, pp.384-93, 1969.

F. L. Ferris, M. D. Davis, T. E. Clemons, L. Lee, E. Y. Chew et al., A simplified severity scale for agerelated macular degeneration: AREDS Report No, Arch Ophthalmol, vol.123, issue.18, pp.1570-1574, 2005.

A. Loewenstein, R. Malach, M. Goldstein, I. Leibovitch, A. Barak et al., Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration, Ophthalmology. mai, vol.110, issue.5, pp.966-70, 2003.

G. L. Soubrane and . Dmlas, , 2007.

H. Schatz and H. R. Mcdonald, Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss, Ophthalmology, vol.96, issue.10, pp.1541-51, 1989.

J. P. Sarks, S. H. Sarks, and M. C. Killingsworth, Evolution of geographic atrophy of the retinal pigment epithelium, Eye (Lond), vol.2, pp.552-77, 1988.

M. J. Lavin, R. J. Marsh, S. Peart, and A. Rehman, Retinal arterial macroaneurysms: a retrospective study of 40 patients, Br J Ophthalmol, vol.71, issue.11, pp.817-842, 1987.

J. Yau, S. L. Rogers, R. Kawasaki, E. L. Lamoureux, J. W. Kowalski et al., Global prevalence and major risk factors of diabetic retinopathy, Diabetes Care. mars, vol.35, issue.3, pp.556-64, 2012.

C. Kaur, W. S. Foulds, and E. A. Ling, Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res, vol.27, pp.622-669, 2008.

, Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group, Ophthalmology. mai, vol.98, issue.5, pp.786-806, 1991.

A. Lecleire-collet, A. Erginay, K. Angioi-duprez, D. , N. Gain et al., Classification simplifiée de la rétinopathie diabétique adaptée au dépistage par photographies du fond d'oeil. /data/revues, vol.29, 2008.

D. Sur,

C. P. Wilkinson, F. L. Ferris, R. E. Klein, P. P. Lee, C. D. Agardh et al., Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales, Ophthalmology. sept, vol.110, issue.9, pp.1677-82, 2003.

L. S. Morse, C. B. Chapman, D. Eliott, J. D. Benner, M. S. Blumenkranz et al., Subretinal hemorrhages in proliferative diabetic retinopathy, Retina, vol.17, issue.2, pp.87-93, 1997.

D. M. Nathan, J. B. Buse, M. B. Davidson, E. Ferrannini, R. R. Holman et al., Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care. janv, vol.32, issue.1, pp.193-203, 2009.

R. R. Holman, S. K. Paul, M. A. Bethel, H. Neil, and D. R. Matthews, Long-term follow-up after tight control of blood pressure in type 2 diabetes, N Engl J Med, vol.359, issue.15, pp.1565-76, 2008.

, Medical management for the prevention and treatment of diabetic macular edema, 2018.

, Haute Autorité de Santé -Stratégie médicamenteuse du contrôle glycémique du diabète de type 2

S. Auriol, L. Mahieu, L. Lequeux, J. C. Quintyn, and V. Pagot-mathis, Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age

, J Fr Ophtalmol. févr, vol.33, issue.2, pp.84-91, 2010.

E. W. Norton, Intraocular gas in the management of selected retinal detachments, Trans Am Acad Ophthalmol Otolaryngol. avr, vol.77, issue.2, pp.85-98, 1973.

E. Masson, Technique et interprétation de l'« optical coherence tomography

. Em-consulte,

D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson et al., Optical coherence tomography. Science, vol.22, issue.5035, pp.1178-81, 1991.

M. Van-velthoven, D. J. Faber, F. D. Verbraak, T. G. Van-leeuwen, and M. D. De-smet, Recent developments in optical coherence tomography for imaging the retina, Prog Retin Eye Res. janv, vol.26, issue.1, pp.57-77, 2007.

A. Chan, J. S. Duker, T. H. Ko, J. G. Fujimoto, and J. S. Schuman, Normal Macular Thickness Measurements in Healthy Eyes Using Stratus Optical Coherence Tomography, Arch Ophthalmol. févr, vol.124, issue.2, pp.193-201, 2006.

G. Staurenghi, S. Sadda, U. Chakravarthy, and R. F. Spaide, International Nomenclature for Optical Coherence Tomography (IN?OCT) Panel. Proposed lexicon for anatomic landmarks in normal posterior segment spectraldomain optical coherence tomography: the IN?OCT consensus, Ophthalmology. août, vol.121, issue.8, pp.1572-1580, 2014.

T. Hirashima, T. Moriya, T. Bun, T. Utsumi, M. Hirose et al., Retina, vol.35, issue.10, pp.1969-78, 2015.

E. Eschwege, A. Basdevant, A. Crine, C. Moisan, and M. Charles, Type 2 diabetes mellitus in France in 2012: results from the ObEpi survey, Diabetes Metab. févr, vol.41, issue.1, pp.55-61, 2015.

C. Delcourt, P. Massin, and M. Rosilio, Epidemiology of diabetic retinopathy: expected vs reported prevalence of cases in the French population, Diabetes Metab. déc, vol.35, issue.6, pp.431-439, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00394359

A. Perrine, C. Lecoffre, and V. Olié, Prévalence de l'hypertension artérielle chez les adultes en France en 2015, étude ESTEBAN. Revue d'Épidémiologie et de, Santé Publique. 1 mars, vol.66, p.50, 2018.

G. Ying, M. G. Maguire, E. Daniel, J. E. Grunwald, O. Ahmed et al., Association between Antiplatelet or Anticoagulant Drugs and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials, Ophthalmology. févr, vol.123, issue.2, pp.352-60, 2016.

S. W. Moon, J. Oh, H. G. Yu, H. Y. Cho, and S. J. Song, Incidence and risk factors for macular hemorrhage following intravitreal ranibizumab injection for neovascular age-related macular degeneration, J Ocul Pharmacol Ther. août, vol.29, issue.6, pp.556-565, 2013.

R. W. Panton, M. F. Goldberg, and M. D. Farber, Retinal arterial macroaneurysms: risk factors and natural history, British Journal of Ophthalmology, vol.74, issue.10, pp.595-600, 1990.

D. Sur,

. Actualisation and . France, Etat des lieux en 2014 et recommandations de surveillance -Point d'information -ANSM : Agence nationale de sécurité du médicament et des produits de santé

J. Ye, Y. Xu, J. He, and L. Lou, Association between aspirin use and age-related macular degeneration: a metaanalysis, Invest Ophthalmol Vis Sci. 25 avr, vol.55, issue.4, pp.2687-96, 2014.

A. Al-hity, D. H. Steel, D. Yorston, D. Gilmour, Z. Koshy et al., Incidence of submacular haemorrhage (SMH) in Scotland: a Scottish Ophthalmic Surveillance Unit (SOSU) study. Eye (Lond), 2018.

R. Klein, B. E. Klein, S. C. Jensen, J. A. Mares-perlman, K. J. Cruickshanks et al., Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III, Ophthalmology. juin, vol.106, issue.6, pp.1056-65, 1999.

W. Smith, J. Assink, R. Klein, P. Mitchell, C. C. Klaver et al., Risk factors for age-related macular degeneration: Pooled findings from three continents, Ophthalmology. avr, vol.108, issue.4, pp.697-704, 2001.

J. C. Javitt, Z. Zhou, M. G. Maguire, S. L. Fine, and R. J. Willke, Incidence of exudative age-related macular degeneration among elderly Americans, Ophthalmology. août, vol.110, issue.8, pp.1534-1543, 2003.

M. Gök, V. L. Karaba?, M. ?. Aslan, Ö. Kara, S. Karaman et al., Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration, Indian J Ophthalmol. juin, vol.65, issue.6, pp.482-489, 2017.

H. Bardak, Y. Bardak, Y. Erçal?k, B. Erdem, G. Arslan et al., Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage, Eur J Ophthalmol. mai, vol.28, issue.3, pp.306-316, 2018.

C. L. Haupert, B. W. Mccuen, G. J. Jaffe, E. R. Steuer, T. A. Cox et al., Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration, Am J Ophthalmol. févr, vol.131, issue.2, pp.208-223, 2001.

M. Waizel, M. G. Todorova, S. Kazerounian, A. Rickmann, B. R. Blanke et al., Efficacy of Vitrectomy Combined with Subretinal Recombinant Tissue Plasminogen Activator for Subretinal versus Subpigment Epithelial versus Combined Hemorrhages, Ophthalmologica, vol.236, issue.3, pp.123-155, 2016.

M. Waizel, M. G. Todorova, A. Rickmann, B. R. Blanke, and P. Szurman, Efficacy of Vitrectomy Combined with Subretinal rtPA Injection with Gas or Air Tamponade, Klin Monbl Augenheilkd. avr, vol.234, issue.4, pp.487-92, 2017.

D. Garcia, L. Mahieu, G. Soubrane, L. Salmon, A. Renouvin et al., Follow-up after surgery for hemorrhagic AMD, J Fr Ophtalmol, vol.39, issue.8, pp.661-668, 2016.

. Zeeburg-ejt-van, J. C. Meurs, and . Van, Literature Review of Recombinant Tissue Plasminogen Activator Used for Recent-Onset Submacular Hemorrhage Displacement in Age-Related Macular Degeneration, OPH, vol.229, issue.1, pp.1-14, 2013.

L. Hesse, J. Schmidt, and P. Kroll, Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefe's, Arch Clin Exp Ophthalmol. 1 mars, vol.237, issue.4, pp.273-280, 1999.

F. Treumer, J. Roider, and J. Hillenkamp, Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage, British Journal of Ophthalmology. 1 mai, vol.96, issue.5, pp.708-721, 2012.

R. P. Singh, C. Patel, and J. E. Sears, Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator, British Journal of Ophthalmology. 1 avr, vol.90, issue.4, pp.429-460, 2006.

A. Ozkaya, G. Erdogan, and H. N. Tarakcioglu, Submacular hemorrhage secondary to age-related macular degeneration managed with vitrectomy, subretinal injection of tissue plasminogen activator, hemorrhage displacement with liquid perfluorocarbon, gas tamponade, and face-down positioning, Saudi J Ophthalmol. déc, vol.32, issue.4, pp.269-74, 2018.

, WHO | International Classification of Functioning, Disability and Health (ICF) [Internet]. WHO

R. Schliermann, P. Heydenreich, T. Bungter, and V. Anneken, Health-related quality of life in working-age adults with visual impairments in Germany, Disabil Rehabil, vol.39, issue.5, pp.428-465, 2017.

J. Leissner, M. Coenen, S. Froehlich, D. Loyola, and A. Cieza, What explains health in persons with visual impairment?, Health Qual Life Outcomes. 3 mai, vol.12, p.65, 2014.

F. Treumer, S. Wienand, K. Purtskhvanidze, J. Roider, and J. Hillenkamp, The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF, Graefes Arch Clin Exp Ophthalmol. juin, vol.255, issue.6, pp.1115-1138, 2017.

H. Lincoff, I. Kreissig, M. Stopa, and D. Uram, A 40 degrees gaze down position for pneumatic displacement of submacular hemorrhage: clinical application and results. Retina (Philadelphia, Pa), janv, vol.28, issue.1, pp.56-65, 2008.

S. R. Bennett, J. C. Folk, C. F. Blodi, and M. Klugman, Factors Prognostic of Visual Outcome in Patients With Subretinal Hemorrhage, American Journal of Ophthalmology. 1 janv, vol.109, issue.1, pp.33-40, 1990.

K. Kadonosono, A. Arakawa, S. Yamane, M. Inoue, T. Yamakawa et al., Displacement of submacular hemorrhages in age-related macular degeneration with subretinal tissue plasminogen activator and air, Ophthalmology. janv, vol.122, issue.1, pp.123-131, 2015.

W. Chang, S. J. Garg, R. Maturi, J. Hsu, A. Sivalingam et al., Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration, Am J Ophthalmol. juin, vol.157, issue.6, pp.1250-1257, 2014.

R. Guthoff, T. Guthoff, T. Meigen, and W. Goebel, Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration, Retina, vol.31, issue.1, pp.36-40, 2011.

E. Dewilde, L. Delaere, I. Vaninbroukx, J. Van-calster, and P. Stalmans, Subretinal tissue plasminogen activator injection to treat submacular haemorrhage during age-related macular degeneration, Acta Ophthalmol. sept, vol.92, issue.6, pp.497-498, 2014.

L. O. Hattenbach, C. Klais, F. H. Koch, and H. O. Gümbel, Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions, Ophthalmology. août, vol.108, issue.8, pp.1485-92, 2001.

J. Hillenkamp, V. Surguch, C. Framme, V. Gabel, and H. G. Sachs, Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator, Graefes Arch Clin Exp Ophthalmol. janv, vol.248, issue.1, pp.5-11, 2010.

H. Schaefer, A. Dwairi, R. Singh, P. Ohrloff, C. Kohnen et al., Can Postoperative Accelerated Lens Opacification be Limited by Lying in « Face-Down Position

, Klin Monbl Augenheilkd. août, vol.232, issue.8, pp.966-75, 2015.

, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses

, En présence des Maîtres de cette FACULTE et de mes chers CONDISCIPLES, je promets et je jure d'être fidèle aux lois de l'Honneur et de la Probité dans l'exercice de la Médecine

, Respectueux et reconnaissant envers mes MAÎTRES, je rendrai à leurs enfants l'instruction que j'ai reçue de leurs pères

, Que les HOMMES m'accordent leur estime si je suis fidèle à mes promesses. Que je sois couvert d'OPPROBRE et méprisé de mes confrères si j'y manque